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Background. South Africa (SA) has a high prevalence of HIV infection with almost 11% of the population aged >2 years living 
with HIV. At the Steve Biko Academic Hospital, Pretoria, the Neurology Department has seen a steady increase in HIV-related 
neurology patients.
Objective. To evaluate the mortality data of this unit as it relates to HIV infection.
Methods. The study was a retrospective analysis of records. Patient mortality statistics for 2006, 2008, 2010 and 2012 were 
analysed regarding cause of death, sex, age and HIV status. 
Results. During 2006, 85 patients died: 33% were HIV-positive, 13% were HIV-negative and 54% had not tested for HIV. By 
2010, these figures were 50%, 22% and 28%, respectively, changing little in 2012 (48%, 28% and 24%, respectively). Causes of 
death in the HIV-positive group were meningitis in 58% – with tuberculous meningitis the most common aetiology – followed 
by strokes (14%), space-occupying lesions (8%) and status epilepticus (7%). Among HIV-positive patients aged 20 - 30 years, a 
larger proportion of young women died than men. In the combined untested and HIV-negative group, strokes accounted for the 
vast majority of deaths. 
Conclusion. Neurological complications of HIV remain common in SA and contribute significantly to the overall mortality in 
our tertiary neurology unit, with TB posing a serious threat. A strong corps of clinical neurologists with training in infective 
neurology is needed urgently in the coming years to care for this growing number of patients.
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The AIDS epidemic in South Africa (SA) 
is continuing. The Department of Health 
estimated that the national HIV prevalence 
among women attending antenatal clinics was 
29.4% in 2009 and 29.5% in 2011, with a higher 
prevalence in KwaZulu-Natal (37.4%) and Mpumalanga (36.7%) 
provinces. [1,2] Furthermore, an alarming HIV incidence of 10.9% 
has been reported among the population aged >2 years.[3] Death 
notification data in SA show that the death rate among young 
women (25 - 34 years) more than quadrupled between 1997 and 
2004, and that among men (30 - 39 years) more than doubled, 
presumably in part due to HIV infection.[4] Unfortunately, 
mortality data are difficult to analyse, as the majority of HIV-
related deaths are misclassified. Thus, the ascertainment of deaths 
related to HIV remains a big concern.[5,6] 
Neurological complications of HIV infection are common. 
In the era prior to highly active antiretroviral therapy 
(HAART), neurological disorders were the first manifestation 
of AIDS in 7 - 20% of patients and prevalence rates of 
opportunistic neurological infections, including cryptococcal 
meningitits (CM), tuberculous meningitis and progressive 
multifocal leukoencephalopathy (PML), ranged from 39 - 70%. 
Toxoplasmic encephalitis and primary central nervous system 
(CNS) lymphoma were common causes of space-occupying 
lesions in HIV-positive patients.[7] In SA, the neurological 
complications that resulted in hospital admissions included 
bacterial and fungal meningitis, mass lesions – especially due 
to toxoplasmosis and tuberculosis (TB) – spinal cord disorders 
and peripheral nerve disorders. Primary CNS lymphoma was 
rarely seen.[8] One study showed TB as the most common cause 
of focal brain lesions in HIV-positive patients,[9] but very few 
cases of PML had been reported until a recent study showed 
that it was a common cause of white-matter lesions in an 
academic hospital in Pretoria.[10] 
The clinical spectrum of neurological manifestations in HIV-
positive patients has changed somewhat since the arrival of 
HAART, and several studies have confirmed that the incidence 
rates of neurological diseases, such as HIV-associated dementia 
and CNS opportunistic infections, are decreasing.[11] Even 
so, a Nigerian study showed that about one-third of patients 
receiving HAART presented to hospital with a neurological 
problem, including neurocognitive problems (53%), distal 
sensory neuropathy (16.4%), meningitis (6.4%), myopathies 
(5.2%), myelopathies (2.4%) and strokes (2%).[12] 
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has been a steady increase in HIV-related neurology cases. This article 
evaluates the mortality data of this tertiary neurology unit as it relates 
to HIV infection. 
Methods
The patient mortality statistics of the neurology unit at Steve Biko 
Academic Hospital were reviewed for years 2006, 2008, 2010 and 2012; 
alternate years were chosen on the presumption that data would not 
change significantly from one year to the next. The hospital has 830 
beds and serves as a major tertiary referral centre in Gauteng Province. 
The Department of Neurology admits patients from the emergency 
department, the neurology outpatient department and from referral 
hospitals. The statistics from the morbidity and mortality meetings are 
stored in the department and were analysed in this study in terms of 
cause of death, sex, age and HIV status. The HIV status of a patient 
is determined whenever a clinical indication exists and knowledge of 
the HIV infection would influence management. The cause of death 
was determined by the treating neurologists’ best clinical opinion in 
the large majority of cases, since autopsies are often not feasible in our 
resource-limited setting. Ethics approval of the study was granted by the 
University of Pretoria. 
Results
The total number of neurological admissions was 533, 446, 510 and 460 
in 2006, 2008, 2010 and 2012, respectively. The total number of deaths 
was 85, 73, 80 and 61, respectively (Table 1).
Of the 85 patients who died in 2006, 28 (33%) were HIV-positive (12 
females, 16 males), 11 (13%) were HIV-negative (6 females, 5 males) 
and 46 (54%) had not had their HIV status tested (26 females, 20 
males). In the HIV-positive group, meningitis was the most common 
cause of death (75%), with TB the most common aetiology, followed by 
CM. Strokes were the second most common cause of death (14%). The 
HIV-negative group had miscellaneous causes of death (strokes, cancer-
related and hypoxia). In 54%, the HIV status had not been determined; 
the most common cause of death in these patients was stroke (41%), 
followed by meningitis (17%). 
Of the 73 patients who died in 2008, 31 (42%; 17 females, 14 
males) were HIV-positive; again, infective causes of death were most 
common at 71%, with TB meningitis in 47% of meningitis cases, 
followed by CM in 26%. Strokes accounted for 23% of HIV-related 
deaths. The HIV-negative group included 13 patients (18%) with 
miscellaneous causes of death (strokes, complications of chronic 
neurological conditions, etc.). In 40% of patients, testing for HIV 
had not been requested; of these, two-thirds died as a result of stroke 
(66%), 17% from complications of status epilepticus and 10% from 
meningitis.
In 2010, 80 patients died. Most had been tested for HIV, and 
half were HIV-positive: 40 (50%; 22 females, 18 males) had a cause 
of death related to HIV infection. Meningitis and other infective 
disorders were the cause of death in 63% (TB 56%, cryptococcal 
22%, S. pneumoniae 17%) and 18% died from seizure complications. 
Miscellaneous causes accounted for the rest of the deaths (strokes, 
various space-occupying lesions, etc.). CD4+ counts were determined 
for nearly 70% of HIV-positive patients (mean 62 × 106 cells/l; range 
2 - 200 × 106). Eighteen patients (22%) were HIV-negative, with 
miscellaneous causes of death (strokes 44%, meningitis, Wernicke 
encephalopathy, chronic neurological disorders, etc.). In 28% (22 
patients), HIV testing had not been performed, and stroke was the 
most common cause of death (55%); 4 (14%) died of status epilepticus 
complications. Meningitis, metastatic disease and space-occupying 
lesions were other causes of death. 
In 2012, 61 patients died: 29 (48%) were HIV-positive (20 females, 9 
males), 17 (28%) were HIV-negative and 15 (24%) had not been tested. 
Again, the majority of HIV-positive patients died of infective causes (20; 
69%), with TB meningitis being the most common cause of death in the 
meningitis group (80%). Strokes accounted for 17% of deaths. CD4+ 
counts were available in 21/29 patients and ranged from 13 - 1 021 × 106 
cells/l (mean 145 × 106). From the retrospective data, it was possible to 
ascertain that 14 patients had not been receiving antiretroviral therapy 
(ART), 4 were receiving ART, and this information was not available for 
11.  Of the 17 deceased patients (28% of total) who were HIV-negative, 
the majority died from strokes (8/17; 47%), meningitis (4/17; 24%) and 
other miscellaneous causes. HIV testing had not been performed in 15 
(24%) patients; most of these patients died from strokes (10/15; 67%) 
and meningitis (3/15; 20%). Fig. 1 shows the HIV status of patients over 
the period that the study was conducted. 
Over the study period, 71 female and 57 male HIV-positive patients 
died. Their age ranges were 14 - 64 and 17 - 61 years for females and 
males, respectively. The age profiles showed a clear difference in the age 
at death between the sexes, with a much higher proportion of women 
dying at age 20 - 30 years than men in the HIV-positive group (19 v. 5, 
respectively) (Fig. 2).
When combining the results of the 4 years of the study, the causes of 
death in the HIV-positive patients included meningitis (58%), strokes 
(14%), space-occupying lesions (8%), status epilepticus (7%) and PML 
(5%) (Fig. 3). Meningitis was most commonly tuberculous (50%), 
followed by cryptococcal (30%) and bacterial (12%). Causes of death 
in the combined HIV-negative and HIV-unknown group are shown 
in Fig. 4. 
Discussion
It is well-known that HIV leads to a wide spectrum of neurological 
complications, ranging from immunological dysregulation to diseases 
caused by immunosuppression, such as cerebral toxoplasmosis, PML 
and primary CNS lymphoma, and to HIV-driven disorders such as 
dementia and polyneuropathies.[13,14] Secondary conditions related to 
HAART and reactive psychiatric disorders also occur. Up to 40% of 
HIV-infected patients may have a neurological disorder[15] and post-
Table 1. Patient admissions, deaths and HIV status over the study period
2006 2008 2010 2012
Patients admitted, N 533 446 510 460
Deaths, n (%) 85 (15.9) 83 (16.3) 80 (15.6) 61 (13.2)
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mortem studies show an even higher proportion of CNS pathology with 
HIV infection.[16] 
Over the study period, an increasing number of patients had been 
tested for HIV infection – from 45% in 2006 to 70% in 2010 and 
almost 80% in 2012, with HIV infection proven in 34% in 2006 and 
approximately 50% in 2010 and 2012. Thus, HIV-related neurological 
disorders are the leading cause of death in our tertiary unit, with at least 
half of all deaths currently directly related to HIV infection. According to 
the South African National HIV Survey of 2008, 10.9% of South Africans 
aged >2 years were infected with HIV in 2008, which compared with 
11.4% in 2002 and 10.8% in 2005, showed some stabilisation.[3] However, 
the prevalence was still growing in people aged >25 years (from 15.6% in 
2005 to 16.8% in 2008), which may be reflected by our findings. Many 
people were unaware of their HIV status and were not receiving HAART, 
although this was not formally assessed in this study. Patients were also 
often referred late in the course of their neurological illness, making 
reversal of established pathology a challenge. 
In this study, infective causes of death in HIV-positive patients 
were preponderant, with TB the most common aetiology. Several 
previous post-mortem studies have shown that infections as a cause 
of death constitute the largest proportion in HIV-positive individuals. 
A study from Botswana[17] concluded that TB was the leading cause 
of death in HIV-positive adults, followed by pneumonia and Kaposi’s 
sarcoma. Another study compared causes of death and mortality rates 
during the pre-, early and late HAART eras, finding that even with 
HAART, infections remained the leading cause of death in HIV-positive 
patients. [18] A recent study[19] showed that the presence of neurological 
disorders in treated HIV/AIDS patients negatively affected survival, 
with the highest mortality hazard ratio occurring in those patients who 
had opportunistic infections of the CNS.[19] 
A high index of suspicion should be maintained for CM and tuberculous 
meningitis in the primary healthcare (PHC) setting, since many patients 
were referred with neurological problems that were already irreversible. 
The new guidelines for the prevention, diagnosis and management of 
CM[20] may go a long way in addressing the problem of late diagnosis of 
CM, and routine screening for cryptococcal antigen and urgent follow-up 
in patients with a CD4+ count <100 cells/µl should be seen as a necessity 
in all PHC facilities. Tuberculous meningitis is often misdiagnosed, even 
if a lumbar puncture is performed, since cerebrospinal fluid (CSF) results 




























Fig. 1. HIV status of patients over the study period, indicating a positive trend 





































       
Fig. 2. Age categories of HIV-positive patients, suggesting that females died of 
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should be started empirically on anti-TB treatment, even if it means that 
some patients may be treated unnecessarily.[21] 
Our mortality data did not include information on ART. This 
information should, in future, be added to our statistics for analysis, as 
the current impression is that many patients are still unaware of their 
HIV status and are treatment-naive. Earlier awareness and initiation 
of ART before immunosuppression should lead to reduced mortality. 
Among the HIV-positive patients in the 20 - 29-year age group, the 
proportion of women who passed away was much higher than men. 
This finding may be related to the results of the South African National 
HIV Survey of 2008,[3] which revealed that the HIV prevalence is 
disproportionally high for females compared with males, peaking in 
the 25 - 29-year age group, with one-third being HIV-positive. In males, 
the prevalence was found to peak in the 30 - 35-year age group (25% 
HIV-positive), which is also comparable to our findings where most 
male deaths occurred at age 30 - 39 years. Intergenerational sex may 
be a contributory factor to the high HIV prevalence in young women, 
many of whom have partners who are ≥5 years older – this number 
has increased from 9.6% in 2005 to 14.5% in 2008. Young girls may be 
particularly vulnerable in such relationships since they lack the skills 
and power to insist on condom use.[3,22] 
Conclusion
Our findings show that neurological complications of HIV infection 
remain common in SA and contribute significantly to the overall 
mortality in our tertiary neurology unit. TB remains a significant threat, 
with many young patients dying as a result of this infection. In the next 
few years, a strong corps of clinical neurologists with special training in 
infective disorders is urgently needed to provide optimal care for this 
large number of patients. 
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